Cargando…
Realizing the Clinical Potential of Immunogenic Cell Death in Cancer Chemotherapy and Radiotherapy
Immunogenic cell death (ICD), which is triggered by exposure of tumor cells to a limited range of anticancer drugs, radiotherapy, and photodynamic therapy, represents a recent innovation in the revitalized and burgeoning field of oncoimmunnotherapy. ICD results in the cellular redistribution and ext...
Autores principales: | Rapoport, Bernardo L., Anderson, Ronald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412296/ https://www.ncbi.nlm.nih.gov/pubmed/30813267 http://dx.doi.org/10.3390/ijms20040959 |
Ejemplares similares
-
Dying of Stress: Chemotherapy, Radiotherapy, and Small-Molecule Inhibitors in Immunogenic Cell Death and Immunogenic Modulation
por: Fabian, Kellsye P., et al.
Publicado: (2022) -
Biomarkers of Radiotherapy-Induced Immunogenic Cell Death
por: Vaes, Rianne D. W., et al.
Publicado: (2021) -
Trial watch: Chemotherapy with immunogenic cell death inducers
por: Vacchelli, Erika, et al.
Publicado: (2012) -
Trial watch: Chemotherapy with immunogenic cell death inducers
por: Vacchelli, Erika, et al.
Publicado: (2013) -
Trial Watch: Chemotherapy with immunogenic cell death inducers
por: Vacchelli, Erika, et al.
Publicado: (2014)